Concepedia

Krishna M. Ella

KM

37

Publications

2.8K

Citations

27

H-Index

1994

Active since

Affiliations

Bharat Biotech (India)(Current)

ICMR-National Institute of Virology

Indian Council of Medical Research

Medical University of South Carolina

All India Institute of Medical Sciences

Krishna M. Ella is an author at Bharat Biotech (India) specializing in medicine, immunology, and vaccine development.

ORCID

Top concepts

Publications per year

1994–2022

37

Publications

37

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial

Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand et al. · The Lancet Infectious Diseases · 2021 · 433 citations · Full text

, , +6

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial

Raches Ella, Siddharth Reddy, Harsh Jogdand et al. · The Lancet Infectious Diseases · 2021 · 360 citations · Full text

Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial

Raches Ella, Siddarth Reddy, William C. Blackwelder et al. · The Lancet · 2021 · 358 citations · Full text

, , +7

Safety and Immunogenicity of a Vi Polysaccharide–Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study

Vineeth Varanasi, Anit Singh, Marcela F. Pasetti et al. · Clinical Infectious Diseases · 2015 · 199 citations · Full text

Protective efficacy of Zika vaccine in AG129 mouse model

K. Sumathy, Bharathi Kulkarni, Ravi Kumar Gondu et al. · Scientific Reports · 2017 · 101 citations · Full text

Rows per page

1–5 of 37